Hu et al. [14] revealed that pitavastatin suppresses Ras/Raf/MEK and PI3K/AKT/mTOR signaling to promote apoptosis and ameliorate angiogenesis in lung cancer cells. This evidence concerns the gene MAP2K7 and lung carcinoma.